These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36209259)

  • 81. The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation.
    Lee J; Lee JG; Kim S; Song SH; Kim BS; Kim HO; Kim MS; Kim SI; Kim YS; Huh KH
    Nephrol Dial Transplant; 2016 Jun; 31(6):1013-21. PubMed ID: 27190360
    [TBL] [Abstract][Full Text] [Related]  

  • 82. ABO-compatible retransplantation after ABO-incompatible infant heart transplantation: absence of donor specific isohemagglutinins.
    Kohler S; Engmann R; Birnbaum J; Fuchs A; Kaczmarek I; Netz H; Kozlik-Feldmann R
    Am J Transplant; 2014 Dec; 14(12):2903-5. PubMed ID: 25293954
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Outcomes after ABO incompatible pediatric liver transplantation are comparable to ABO identical/compatible transplant.
    Lemoine CP; Brandt KA; Keswani M; Superina R
    Front Pediatr; 2023; 11():1092412. PubMed ID: 37325348
    [TBL] [Abstract][Full Text] [Related]  

  • 84. De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation.
    Koch M; Wiech T; Marget M; Peine S; Thude H; Achilles EG; Fischer L; Lehnhardt A; Thaiss F; Nashan B
    Clin Transplant; 2015 Nov; 29(11):1021-8. PubMed ID: 26333844
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Blood group antigen-targeting peptide suppresses anti-blood group antibody binding to antigen in renal glomerular capillaries after ABO-incompatible blood reperfusion.
    Yoneyama T; Hatakeyama S; Tobisawa Y; Yamamoto H; Imanishi K; Okamoto T; Tokui N; Sugiyama N; Suzuki Y; Kudo S; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Fukuda MN; Ohyama C
    Transplantation; 2013 Feb; 95(3):418-25. PubMed ID: 23274971
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations: survey of 101 cases to determine whether splenectomies are necessary for successful transplantation.
    Ishida H; Koyama I; Sawada T; Utsumi K; Murakami T; Sannomiya A; Tsuji K; Yoshimura N; Tojimbara T; Nakajima I; Tanabe K; Yamaguchi Y; Fuchinoue S; Takahashi K; Teraoka S; Ito K; Toma H; Agishi T
    Transplantation; 2000 Aug; 70(4):681-5. PubMed ID: 10972229
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Desensitization with the Use of an Antibody Removal-Free Protocol in ABO-Incompatible Kidney Transplant Recipients with a Low Anti-A/B Antibody Titer.
    Nanmoku K; Shinzato T; Kubo T; Shimizu T; Kimura T; Yagisawa T
    Transplant Proc; 2018 May; 50(4):982-986. PubMed ID: 29731097
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Molecular Patterns Discriminate Accommodation and Subclinical Antibody-mediated Rejection in Kidney Transplantation.
    Hruba P; Krejcik Z; Stranecky V; Maluskova J; Slatinska J; Gueler F; Gwinner W; Bräsen JH; Wohlfahrtova M; Parikova A; Osickova K; Fronek J; Seda O; Prefertusova L; Honsova E; Viklicky O
    Transplantation; 2019 May; 103(5):909-917. PubMed ID: 30801516
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Anti-IL-2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid-term outcomes after ABO-incompatible kidney transplantation.
    Del Bello A; Divard G; Belliere J; Congy-Jolivet N; Lanfranco L; Ricard R; Delas A; Colombat M; Esposito L; Hebral AL; Cointault O; Lefaucheur C; Loupy A; Kamar N
    Clin Transplant; 2019 Oct; 33(10):e13681. PubMed ID: 31369170
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The effect of desensitization therapy in kidney transplantation.
    Kim YC; Yu MY; Lee JP; Lee H; Min SI; Ha J; Kim YS
    Clin Exp Nephrol; 2018 Feb; 22(1):179-187. PubMed ID: 28634772
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation.
    Sugiyama K; Hyodo Y; Aikawa A
    Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study.
    Lonze BE; Bae S; Kraus ES; Holechek MJ; King KE; Alachkar N; Naqvi FF; Dagher NN; Sharif A; Desai NM; Segev DL; Montgomery RA
    Transpl Int; 2017 Sep; 30(9):874-883. PubMed ID: 28403566
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience.
    Habicht A; Bröker V; Blume C; Lorenzen J; Schiffer M; Richter N; Klempnauer J; Haller H; Lehner F; Schwarz A
    Nephrol Dial Transplant; 2011 Dec; 26(12):4124-31. PubMed ID: 21622990
    [TBL] [Abstract][Full Text] [Related]  

  • 94. ABO-incompatible renal transplantation in developing world - crossing the immunological (and mental) barrier.
    Jha PK; Bansal SB; Sethi SK; Jain M; Sharma R; Nandwani A; Phanish MK; Duggal R; Tiwari AK; Ghosh P; Ahlawat R; Kher V
    Indian J Nephrol; 2016; 26(2):113-8. PubMed ID: 27051135
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Excellent outcome after desensitization in high immunologic risk kidney transplantation.
    Lim JH; Cho JH; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Yoo ES; Won DI; Kim CD
    PLoS One; 2019; 14(9):e0222537. PubMed ID: 31550258
    [TBL] [Abstract][Full Text] [Related]  

  • 97. ABO-Incompatible Liver Transplantation - A Review of the Historical Background and Results.
    Dahlgren US; Bennet W
    Int Rev Immunol; 2019; 38(3):118-128. PubMed ID: 31012340
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Clinical Outcomes and Results of Pathological Findings of 1-year Protocol Biopsy in Recipients of ABO-Incompatible Living Donor Kidney Transplantants.
    Yokoyama T; Konno O; Kihara Y; Nakamura Y; Iwamoto H; Kawachi S
    Transplant Proc; 2016 Apr; 48(3):831-5. PubMed ID: 27234746
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Long-term results of ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab.
    Genberg H; Kumlien G; Wennberg L; Tydén G
    Transplantation; 2007 Dec; 84(12 Suppl):S44-7. PubMed ID: 18162990
    [TBL] [Abstract][Full Text] [Related]  

  • 100. ABO-Incompatible Heart Transplant in Infants: A UNOS Database Review.
    Kozik D; Sparks J; Trivedi J; Slaughter MS; Austin E; Alsoufi B
    Ann Thorac Surg; 2021 Aug; 112(2):589-594. PubMed ID: 32888926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.